The JAK1-STAT1 signaling pathway triggers inflammation responses in chronic obstructive sleep apnea rat model. [PDF]
PLoS OneYang L, He J.
europepmc +1 more source
Rationale, Design and Methods of the Filgotinib Initial Response Study in Rheumatoid Arthritis (FIRST-RA). [PDF]
Rheumatol TherPongratz G +6 more
europepmc +1 more source
Long-term clinical outcomes with filgotinib in ulcerative colitis: 12-month results from the FILGUITO study. [PDF]
World J GastroenterolCaballero-Mateos AM +13 more
europepmc +1 more source
Filgotinib in the treatment of infl ammatory bowel diseases
Gastroenterologie a hepatologie, 2023 openaire +1 more source
Revisiting Janus kinases as molecular drug targets for rheumatic diseases. [PDF]
Front Med (Lausanne)Kwon S.
europepmc +1 more source
Single-Cell Computational Frameworks for Quantifying BET Bromodomain Inhibitor Resistance and Screening Re-Sensitizer Drugs in Triple-Negative Breast Cancer. [PDF]
Adv Sci (Weinh)Liu H +6 more
europepmc +1 more source
Updated review of Janus kinase inhibitors for the management of inflammatory bowel disease. [PDF]
World J Gastrointest Pharmacol TherMalakar S, Giri S, Jena A, Nath P.
europepmc +1 more source
Corrigendum to "Preparation of colon-targeted pellets loaded with filgotinib/berberine hydrochloride and Their application in ulcerative colitis therapy" [International Journal of Pharmaceutics: X 2025 (10) 100415]. [PDF]
Int J Pharm XWang J +5 more
europepmc +1 more source
Efficacy/Effectiveness, Safety and Treatment Persistence of Filgotinib in Rheumatoid Arthritis: A Narrative Review of Clinical Trials and Real-World Evidence. [PDF]
Rheumatol TherTanaka Y +4 more
europepmc +1 more source
Janus Kinase Inhibitor Discontinuation at a UK Tertiary Centre: A Retrospective Study. [PDF]
CureusBland K, Jubber A, Ganguly S, Moorthy A.
europepmc +1 more source